What to Expect at FDA Following Commissioner Gottlieb's Departure

Retrieved on: 2019-03-06 05:22:30

Tags for this article:

Health

Food and Drug Administration

Scott Gottlieb

United States administrative law

United States Department of Health and Human Services

American Enterprise Institute

Food law

Criticism of the Food and Drug Administration

Commissioner of Food and Drugs

Stephen Ostroff

United States v. Regenerative Sciences, LLC

Click the tags to see associated articles and topics

What to Expect at FDA Following Commissioner Gottlieb's Departure. View article details on HISWAI:

Excerpt

<div>Dr. Abernathy had been the chief medical officer and chief scientific officer at <b>Flatiron Health</b>, a subsidiary of Roche focused on using real world data to ...</div>

Article found on:

View Original Article